The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
Open accessAbstract
BACKGROUND: The management of metastatic breast cancer requires monitoring of the tumor burden to determine the response to treatment, and improved biomarkers are needed. Biomarkers such as cancer antigen 15-3 (CA 15-3) and circulating tumor cells have been widely studied. However, circulating cell-free DNA carrying tumor-specific alterations (circulating tumor DNA) has not been extensively investigated or compared with other circulating biomarkers in breast cancer. METHODS: We compared the radiographic imaging of tumors with the assay of circulating tumor DNA, CA 15-3, and circulating tumor cells in 30 women with metastatic breast cancer who were receiving systemic therapy. We used targeted or whole-genome sequencing to identify somatic genomic alterations and designed personalized assays to quantify circulating tumor DNA in serially collected plasma specimens. CA 15-3 levels and numbers of circulating tumor cells were measured at identical time points. RESULTS: Circulating tumor DNA was successfully detected in 29 of the 30 women (97%) in whom somatic genomic alterations were identified; CA 15-3 and circulating tumor cells were detected in 21 of 27 women (78%) and 26 of 30 women (87%), respectively. Circulating tumor DNA levels showed a greater dynamic range, and greater correlation with changes in tumor burden, than did CA 15-3 or circulating tumor cells. Among the measures tested, circulating tumor DNA provided the earliest measure of treatment response in 10 of 19 women (53%). CONCLUSIONS: This proof-of-concept analysis showed that circulating tumor DNA is an informative, inherently specific, and highly sensitive biomarker of metastatic breast cancer. (Funded by Cancer Research UK and others.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“it has recently become apparent that vertebrate specific chromatin complexes such as the HUSH complex can be major regulators of the LINE-1 family of retrotransposons 218,219 .”
From The roles of DNA, RNA and histone methylation in ageing and cancer (2019) · cites this paper as [219]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1994) · doi:10.1201/9780429246593 · Cited by 40,500
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
Eisenhauer, E. A., Therasse, P., Bogaerts, J., Schwartz, L. H., Sargent, D., Ford, R., Dancey, J., Arbuck, S., Gwyther, S., Mooney, M., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.10.026 · Cited by 29,534
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C. D., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,468
An Introduction to the Bootstrap
Efron, B., & Tibshirani, R. J. (1993) · doi:10.1007/978-1-4899-4541-9 · Cited by 21,230
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
METABRIC Group, Curtis, C., Shah, S. P., Chin, S.-F., Turashvili, G., Rueda, O. M., Dunning, M. J., Speed, D., Lynch, A. G., Samarajiwa, S., et al. (2012) · Nature · doi:10.1038/nature10983 · Cited by 6,097
Self-citationCirculating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A., Matera, J., Miller, M. C., Reuben, J. M., Doyle, G. V., Allard, W. J., Terstappen, L. W. M. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040766 · Cited by 4,602
Cox’s regression model for counting processes: A large sample study
Andersen, P. K., & Gill, R. D. (1982) · The Annals of Statistics · doi:10.1214/aos/1176345976 · Cited by 4,419
Isolation of rare circulating tumour cells in cancer patients by microchip technology
Nagrath, S., Sequist, L. V. D., Maheswaran, S., Bell, D. W., Irimia, D., Ulkus, L., Smith, M. R., Kwak, E. L., Digumarthy, S. R., Muzikansky, A., et al. (2007) · Nature · doi:10.1038/nature06385 · Cited by 3,595
Cell-free nucleic acids as biomarkers in cancer patients
Schwarzenbach, H., Hoon, D. S. �., & Pantel, K. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3066 · Cited by 2,897
Flagged first, then by citations
1 of the 44 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Lauro S, 1999, Anticancer Res, 19, 3511
- Chen X, 1999, Clin Cancer Res, 5, 2297
Cited by
Sorted by citations
Items 201–300 of 1,003
Tsao, S. C., Weiss, J. M., Hudson, C., Christophi, C., Cebon, J. S., Behren, A., & Dobrovic, A. (2015) · Scientific Reports · doi:10.1038/srep11198 · Cited by 173
Profile of the Roche cobas® EGFR mutation test v2 for non-small cell lung cancer
Malapelle, U., Sirera, R., Lewintre, E. J., Reclusa, P., Fariñas, S. C., Blasco, A., Pisapia, P., Rolfo, C. D., & Camps, C. (2017) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2017.1288568 · Cited by 174
Widschwendter, M., Zikán, M., Wahl, B., Lempiäinen, H., Paprotka, T., Evans, I., Jones, A., Ghazali, S., Reisel, D., Eichner, J., et al. (2017) · Genome Medicine · doi:10.1186/s13073-017-0500-7 · Cited by 176
Lam, W. K., Jiang, P., Chan, K. C. A., Cheng, S. H., Zhang, H., Peng, W., Tse, O. Y. O., Tong, Y. K., Gai, W., Zee, B. C.-Y., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1804184115 · Cited by 173
Messaoudi, S. E., Mouliere, F. C., du Manoir, S., Mollévi, C., Gillet, B., Nouaille, M., Fiess, C., Lopez‐Crapez, E., Bibeau, F., Theillet, C. G., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0297 · Cited by 171
Hadano, N., Murakami, Y., Uemura, K., Hashimoto, Y., Kondo, N., Nakagawa, N., Sueda, T., & Hiyama, E. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.175 · Cited by 173
Fackler, M. J., Bujanda, Z. A. L., Umbricht, C. B., Teo, W. W., Cho, S., Zhang, Z., Visvanathan, K., Jeter, S. C., Argani, P., Wang, C., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3392 · Cited by 170
Jamal‐Hanjani, M., Wilson, G. A., Horswell, S. D., Mitter, R., Sakarya, O., Constantin, T. P., Salari, R., Kırkızlar, E., Sigurjonsson, S., Pelham, R. J., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw037 · Cited by 174
Peng, Y., Mei, W., Ma, K., & Zeng, C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.763790 · Cited by 167
Microfluidic technologies for circulating tumor cell isolation
Cho, H., Kim, J., Song, H., Sohn, K. Y., Jeon, M., & Han, K.-H. (2018) · The Analyst · doi:10.1039/c7an01979c · Cited by 167
Meng, Y., Pople, C. B., Suppiah, S., Llinas, M., Huang, Y., Sahgal, A., Perry, J., Keith, J. L., Davidson, B., Hamani, C., et al. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab057 · Cited by 168
Cancer biomarkers: Written in blood
Yong, E. (2014) · Nature · doi:10.1038/511524a · Cited by 167
Guttery, D. S., Page, K., Hills, A., Woodley, L., Marchese, S. D., Rghebi, B., Hastings, R. K., Luo, J., Pringle, J. H., Stebbing, J., et al. (2015) · Clinical Chemistry · doi:10.1373/clinchem.2015.238717 · Cited by 170
SeekDeep: single-base resolution de novo clustering for amplicon deep sequencing
Hathaway, N. J., Parobek, C. M., Juliano, J. J., & Bailey, J. A. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx1201 · Cited by 165
Ulz, P., Belic, J., Graf, R., Auer, M., Lafer, I., Fischereder, K., Webersinke, G., Pummer, K., Augustin, H., Pichler, M., et al. (2016) · Nature Communications · doi:10.1038/ncomms12008 · Cited by 159
van Dessel, L. F., Beije, N., Helmijr, J., Vitale, S. R., Kraan, J., Look, M. P., de Wit, R., Sleijfer, S., Jansen, M. P. H. M., Martens, J. W. M., et al. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12037 · Cited by 163
Ultratrace DNA Detection Based on the Condensing‐Enrichment Effect of Superwettable Microchips
Xu, L., Chen, Y., Gao, Y., Shi, W., Dai, B., Li, G., Cao, Y., Wen, Y., Zhang, X., & Wang, S. (2015) · Advanced Materials · doi:10.1002/adma.201502982 · Cited by 160
Rossi, G., Mu, Z., RADEMAKER, A. W., Austin, L., Strickland, K. S., Costa, R. L. B., Nagy, R. J., Zagonel, V., Taxter, T., Behdad, A., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2092 · Cited by 161
Alterations in PTEN and ESR1 promote clinical resistance to alpelisib plus aromatase inhibitors
Razavi, P., Dickler, M. N., Shah, P. D., Toy, W., Brown, D. N., Won, H. H., Li, B. T., Shen, R., Vasan, N., Modi, S., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0047-1 · Cited by 163
Goh, J. Y., Feng, M., Wang, W., Oguz, G., Yatim, S. M. J. M., Lee, P. L., Bao, Y., Lim, T. H., Wang, P., Tam, W. L., et al. (2017) · Nature Medicine · doi:10.1038/nm.4405 · Cited by 158
Circulating tumor cells and circulating tumor DNA for precision medicine: dream or reality?
Ignatiadis, M., & Dawson, S. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu480 · Cited by 161
Self-citationEvaluation of pre-analytical factors affecting plasma DNA analysis
Markus, H., Contente‐Cuomo, T., Farooq, M., Liang, W. S., Borad, M. J., Sivakumar, S., Gollins, S., Tran, N. L., Dhruv, H., Berens, M. E., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-25810-0 · Cited by 156
Self-citationAccessing Genetic Information with Liquid Biopsies
Cai, X., Jankú, F., Zhan, Q., & Fan, J. (2015) · Trends in Genetics · doi:10.1016/j.tig.2015.06.001 · Cited by 157
Sorber, L., Zwaenepoel, K., Deschoolmeester, V., Schil, P. E. V., van Meerbeeck, J. P., Lardon, F., Rolfo, C. D., & Pauwels, P. (2016) · Lung Cancer · doi:10.1016/j.lungcan.2016.04.026 · Cited by 159
Tjensvoll, K., Lapin, M., Buhl, T., Oltedal, S., Berry, K. S.-O., Gilje, B., Søreide, J. A., Javle, M. M., Nordgård, O., & Smaaland, R. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.11.012 · Cited by 157
Caers, J., Garderet, L., Kortüm, K. M., O'Dwyer, M. E., van de Donk, N. W. C. J., Binder, M., Dold, S. M., Gay, F., Corre, J., Beguin, Y. P., et al. (2018) · Haematologica · doi:10.3324/haematol.2018.189159 · Cited by 153
Cavo, M., Caria, M., Pulsoni, I., Beltrame, F., Fato, M., & Scaglione, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-23250-4 · Cited by 162
Shao, N., Han, X., Song, Y., Zhang, P., & Qin, L. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b02925 · Cited by 153
Triple Negative Breast Cancer: A Review of Present and Future Diagnostic Modalities
Dass, S. A., Tan, K. L., Rajan, R. S., Mokhtar, N. F., Adzemi, E. R. M., Rahman, W. F. W. A., Din, T. A. D. A. T., & Balakrishnan, V. (2021) · Medicina · doi:10.3390/medicina57010062 · Cited by 165
Use of Liquid Biopsies in Clinical Oncology: Pilot Experience in 168 Patients
Schwaederle, M. C., Husain, H., Fanta, P. T., Piccioni, D. E., Kesari, S., Schwab, R. B., Patel, S. P., Harismendy, O., Ikeda, M., Parker, B. A., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0318 · Cited by 154
Tumor Cell–Free DNA Copy Number Instability Predicts Therapeutic Response to Immunotherapy
Weiss, G. J., Beck, J., Braun, D. P., Bornemann-Kolatzki, K., Barilla, H., Cubello, R., Quan, W., Sangal, A., Khemka, V., Waypa, J., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0231 · Cited by 149
Schwaederle, M. C., Husain, H., Fanta, P. T., Piccioni, D. E., Kesari, S., Schwab, R. B., Banks, K. C., Lanman, R. B., Talasaz, A. H., Parker, B. A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7110 · Cited by 151
Advances in Porous Silicon–Based Nanomaterials for Diagnostic and Therapeutic Applications
Tieu, T., Alba, M., Elnathan, R., Cifuentes‐Rius, A., & Voelcker, N. H. (2018) · Advanced Therapeutics · doi:10.1002/adtp.201800095 · Cited by 150
Recent Progress in Isolation and Detection of Extracellular Vesicles for Cancer Diagnostics
Wang, W., Luo, J., & Wang, S. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201800484 · Cited by 151
Lok, S. W., Whittle, J. R., Vaillant, F., Teh, C. E., Lo, L. L., Policheni, A. N., Bergin, A. R. T., Desai, J., Ftouni, S., Gandolfo, L. C., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-1151 · Cited by 148
Self-citationClinical and molecular complexity of breast cancer metastases
Kimbung, S., Loman, N., & Hedenfalk, I. A. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.08.009 · Cited by 154
Cheng, F., Zhao, J., & Zhao, Z. (2015) · Briefings in Bioinformatics · doi:10.1093/bib/bbv068 · Cited by 151
Madic, J., Kiialainen, A., Bidard, F., Birzele, F., Ramey, G., Leroy, Q., Frio, T. R., Vaucher, I., Raynal, V., Bernard, V., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29265 · Cited by 153
Hrebien, S., Citi, V., García-Murillas, I., Cutts, R., Fenwick, K., Kozarewa, I., McEwen, R. K., Ratnayake, J., Maudsley, R., Carr, T. H., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz085 · Cited by 151
Zhang, P., Wu, X., Gardashova, G., Yang, Y., Zhang, Y., Xu, L., & Zeng, Y. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aaz2878 · Cited by 147
Pérez-Barrios, C., Nieto-Alcolado, I., Torrente, M., Jiménez‐Sánchez, C., Calvo, V., Gutiérrez-Sanz, L., Palka, M., Donoso-Navarro, E., Provencio, M., & Romero, A. (2016) · Translational Lung Cancer Research · doi:10.21037/tlcr.2016.12.03 · Cited by 145
He, C., Liu, C., Jiang, J., Luo, G., Yu, L., Jin, K., Guo, M., Zhang, Z., Xu, J., Liu, L., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30650 · Cited by 145
Promises and Pitfalls of Using Liquid Biopsy for Precision Medicine
Rossi, G., & Ignatiadis, M. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-3402 · Cited by 146
Clinical validity of saliva and novel technology for cancer detection
Kaczor‐Urbanowicz, K. E., Fang, W., Rao, S. L., Kim, J., Shin, H., Cheng, J. C., Tu, M. K., Wong, D. T., & Kim, Y. H. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.05.007 · Cited by 151
PIK3CA mutations in serum DNA are predictive of recurrence in primary breast cancer patients
Oshiro, C., Kagara, N., Naoi, Y., Shimoda, M., Shimomura, A., Maruyama, N., Shimazu, K., Kim, S. J., & Noguchi, S. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3322-6 · Cited by 145
Schreuer, M. S., Meersseman, G., Herrewegen, S. V. D., Jansen, Y. J. L., Chevolet, I., Bott, A., Wilgenhof, S., Seremet, T., Jacobs, B., Buyl, R., et al. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-0852-6 · Cited by 148
Nanoplasmonic biosensor: Detection and amplification of dual bio-signatures of circulating tumor DNA
Anh, N. T. V., & Sim, S. J. (2014) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2014.09.003 · Cited by 143
Drug discovery in advanced prostate cancer: translating biology into therapy
Yap, T. A., Smith, A. D., Ferraldeschi, R., Al‐Lazikani, B., Workman, P., & Bono, J. S. D. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.120 · Cited by 143
Endocrine treatment in breast cancer: Cure, resistance and beyond
Tryfonidis, K., Zardavas, D., Katzenellenbogen, B. S., & Piccart, M. J. (2016) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2016.08.008 · Cited by 145
Liquid Biopsy as a Tool for the Diagnosis, Treatment, and Monitoring of Breast Cancer
de Freitas, A. J. A., Causin, R. L., Varuzza, M. B., Calfa, S., Filho, C. M. T. H., Komoto, T. T., Souza, C. D. P., & Marques, M. M. C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179952 · Cited by 150
A Framework for Biobank Sustainability
Watson, P. H., Nussbeck, S. Y., Carter, C., O’Donoghue, S., Cheah, S., Matzke, L. A. M., Barnes, R. O., Bartlett, J. M. S., Carpenter, J. E., Grizzle, W. E., et al. (2014) · Biopreservation and Biobanking · doi:10.1089/bio.2013.0064 · Cited by 143
Tumor heterogeneity in the clinic: is it a real problem?
Jankú, F. (2013) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834013517414 · Cited by 144
The dynamic range of circulating tumor DNA in metastatic breast cancer
Heidary, M., Auer, M., Ulz, P., Heitzer, E., Petru, E., Gasch, C., Riethdorf, S., Mauermann, O., Lafer, I., Pristauz, G., et al. (2014) · Breast Cancer Research · doi:10.1186/s13058-014-0421-y · Cited by 145
Circulating Tumor DNA to Monitor Metastatic Breast Cancer
Dawson, S.-J., Rosenfeld, N., & Caldas, C. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1306040 · Cited by 140
Self-citationCancer Diagnosis Using a Liquid Biopsy: Challenges and Expectations
Castro-Giner, F., Gkountela, S., Donato, C., Alborelli, I., Quagliata, L., Ng, C. K. Y., Piscuoglio, S., & Aceto, N. (2018) · Diagnostics · doi:10.3390/diagnostics8020031 · Cited by 142
Klega, K. S., Imamović, A., Ha, G., Clapp, A. N., Meyer, S. C., Ward, A., Clinton, C., Nag, A., Allen, E. M. V., Mullen, E. A., et al. (2018) · JCO Precision Oncology · doi:10.1200/po.17.00285 · Cited by 142
Παναγοπούλου, Μ., Karaglani, M., Balgkouranidou, I., Biziota, E., Koukaki, T., Karamitrousis, E., Nena, E., Tsamardinos, I., Kolios, G. C., Lianidou, E. S., et al. (2019) · Oncogene · doi:10.1038/s41388-018-0660-y · Cited by 139
Chae, Y. K., & Oh, M. S. (2018) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.09.022 · Cited by 142
One-step RT-droplet digital PCR: a breakthrough in the quantification of waterborne RNA viruses
Rački, N., Morisset, D., Gutiérrez‐Aguirre, I., & Ravnikar, M. (2013) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-013-7476-y · Cited by 142
The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicine
Vassy, J., Lautenbach, D. M., McLaughlin, H., Kong, S., Christensen, K. D., Krier, J., Kohane, I., Feuerman, L. Z., Blumenthal-Barby, J., Roberts, J., et al. (2014) · Trials · doi:10.1186/1745-6215-15-85 · Cited by 148
Circulating biomarkers to monitor cancer progression and treatment
Rapisuwon, S., Vietsch, E. E., & Wellstein, A. (2016) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2016.05.004 · Cited by 143
Husain, H., Melnikova, V. O., Kosco, K. A., Woodward, B. D., More, S., Pingle, S. C., Weihe, E., Park, B. H., Tewari, M., Erlander, M. G., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0454 · Cited by 137
Chae, Y. K., Davis, A. A., Jain, S., Santa-Maria, C. A., Flaum, L., Beaubier, N. T., Platanias, L. C., Gradishar, W. J., Giles, F. J., & Cristofanilli, M. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0061 · Cited by 140
Application of liquid biopsy in precision medicine: opportunities and challenges
Wang, J., Chang, S., Li, G., & Sun, Y. (2017) · Frontiers of Medicine · doi:10.1007/s11684-017-0526-7 · Cited by 140
Liquid Biopsy in Head and Neck Cancer: Promises and Challenges
Nonaka, T., & Wong, D. T. (2018) · Journal of Dental Research · doi:10.1177/0022034518762071 · Cited by 140
Sannachi, L., Tadayyon, H., Naini, A. S., Tran, W. T., Gandhi, S., Wright, F. C., Oelze, M. L., & Czarnota, G. J. (2014) · Medical Image Analysis · doi:10.1016/j.media.2014.11.009 · Cited by 135
Cell-free circulating tumor DNA in cancer
Qin, Z., Ljubimov, V. A., Zhou, C., Tong, Y., & Liang, J. (2016) · 癌症：英文版 · doi:10.1186/s40880-016-0092-4 · Cited by 137
Guibert, N. M., Hu, Y., Feeney, N. B., Kuang, Y., Plagnol, V., Jones, G. R., Howarth, K., Beeler, J. F., Paweletz, C. P., & Oxnard, G. R. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy005 · Cited by 135
Lapin, M., Oltedal, S., Tjensvoll, K., Buhl, T., Smaaland, R., Garresori, H., Javle, M. M., Glenjen, N. I., Abelseth, B. K., Gilje, B., et al. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1677-2 · Cited by 135
Qian, W., Zhang, Y., & Chen, W. (2015) · Small · doi:10.1002/smll.201403658 · Cited by 135
Next-generation sequencing technologies: breaking the sound barrier of human genetics
Bahassi, E. M., & Stambrook, P. J. (2014) · Mutagenesis · doi:10.1093/mutage/geu031 · Cited by 138
Breast cancer: The translation of big genomic data to cancer precision medicine
Low, S., Zembutsu, H., & Nakamura, Y. (2017) · Cancer Science · doi:10.1111/cas.13463 · Cited by 142
Mathai, R. A., Vidya, R. V. S., Reddy, B. S., Thomas, L., Udupa, K., Kolesar, J., & Rao, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8030373 · Cited by 139
Circulating tumor cells and DNA as liquid biopsies
Heitzer, E., Auer, M., Ulz, P., Geigl, J. B., & Speicher, M. R. (2013) · Genome Medicine · doi:10.1186/gm477 · Cited by 130
Using circulating cell-free DNA to monitor personalized cancer therapy
Oellerich, M., Schütz, E., Beck, J., Kanzow, P., Plowman, P. N., Weiss, G. J., & Walson, P. D. (2017) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2017.1299683 · Cited by 133
Sun, X., Bao, J., & Shao, Y. (2016) · Scientific Reports · doi:10.1038/srep22498 · Cited by 133
Evaluation of commercial kits for purification of circulating free DNA
Diefenbach, R. J., Lee, J., Kefford, R. F., & Rizos, H. (2018) · Cancer Genetics · doi:10.1016/j.cancergen.2018.08.005 · Cited by 129
High-resolution characterization of sequence signatures due to non-random cleavage of cell-free DNA
Chandrananda, D., Thorne, N., & Bahlo, M. (2015) · BMC Medical Genomics · doi:10.1186/s12920-015-0107-z · Cited by 130
van Ginkel, J. H., Huibers, M. M. H., van Es, R. J. J., de Bree, R., & Willems, S. M. (2017) · BMC Cancer · doi:10.1186/s12885-017-3424-0 · Cited by 128
Rothé, F., Silva, M. J., Venet, D., Campbell, C., Bradburry, I., Rouas, G., de Azambuja, E., Maetens, M., Fumagalli, D., Rodrik-Outmezguine, V. S., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2521 · Cited by 128
Self-citationMetastasis of circulating tumor cells: Favorable soil or suitable biomechanics, or both?
Azevedo, A. S., Follain, G., Patthabhiraman, S., Harlepp, S., & Goetz, J. G. (2015) · Cell Adhesion & Migration · doi:10.1080/19336918.2015.1059563 · Cited by 132
Biopsies: next-generation biospecimens for tailoring therapy
Basik, M., Aguilar‐Mahecha, A., Rousseau, C., Diaz, Z., Tejpar, S., Spatz, A., Greenwood, C. M. T., & Batist, G. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.101 · Cited by 126
Smith, C. G., Moser, T., Burge, J., Eldridge, M., Riediger, A. L., Mouliere, F. C., Chandrananda, D., Heider, K., Wan, J. C. M., Warren, A. Y., et al. (2020) · Genome Medicine · doi:10.1186/s13073-020-00723-8 · Cited by 126
Self-citationGay, L. J., Baker, A., & Graham, T. A. (2016) · F1000Research · doi:10.12688/f1000research.7210.1 · Cited by 129
The value of cell‐free DNA for molecular pathology
Stewart, C. M., Kothari, P. D., Mouliere, F. C., Mair, R. J., Somnay, S., Benayed, R., Zehir, A., Weigelt, B., Dawson, S., Arcila, M. E., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5048 · Cited by 129
Self-citationJovelet, C., Ileana, E. E., Deley, M. L., Motté, N., Rosellini, S., Romero, A., Lefèbvre, C., Pedrero, M., Pata-Merci, N., Droin, N. M., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2470 · Cited by 132
Liquid Biopsy in Clinical Management of Breast, Lung, and Colorectal Cancer
Hench, I. B., Hench, J., & Tolnay, M. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00009 · Cited by 126
Diagnostic and prognostic value of circulating tumor-related DNA in cancer patients
Marzese, D. M., Hirose, H., & Hoon, D. S. �. (2013) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2013.845088 · Cited by 123
Circulating Free DNA as Biomarker and Source for Mutation Detection in Metastatic Colorectal Cancer
Spindler, K.-L. G., Pallisgaard, N., Andersen, R. F., Brandslund, I., & Jakobsen, A. K. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0108247 · Cited by 124
Kim, H.-Y., Lee, K., Kim, S., Kwon, Y., Chun, Y., & Choi, H. (2016) · Oncotarget · doi:10.18632/oncotarget.11560 · Cited by 124
Fernández-García, D., Hills, A., Page, K., Hastings, R. K., Toghill, B. J., Goddard, K. S., Ion, C., Ogle, O., Boydell, A., Gleason, K. L. T., et al. (2019) · Breast Cancer Research · doi:10.1186/s13058-019-1235-8 · Cited by 126
Cell‐free circulating tumour DNA as a liquid biopsy in breast cancer
Mattos‐Arruda, L. D., & Caldas, C. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.12.001 · Cited by 124
Self-citationCirculating tumor DNA detection in lung cancer patients before and after surgery
Guo, N., Lou, F., Ma, Y., Li, J., Yang, B., Chen, W., Ye, H., Zhang, J.-B., Zhao, M.-Y., Wu, W., et al. (2016) · Scientific Reports · doi:10.1038/srep33519 · Cited by 124
Circulating breast-derived DNA allows universal detection and monitoring of localized breast cancer
Moss, J., Zick, A., Grinshpun, A., Carmon, E., Maoz, M., Ochana, B. L., Abraham, O. A., Arieli, O., Germansky, L., Meir, K., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2019.11.014 · Cited by 122
Cao, J., Shi, X., Gurav, D. D., Huang, L., Su, H., Li, K., Niu, J., Zhang, M., Wang, Q., Jiang, M., et al. (2020) · Advanced Materials · doi:10.1002/adma.202000906 · Cited by 123
Chen, Y.-H., Hancock, B. A., Solzak, J. P., Brinza, D., Scafe, C., Miller, K. D., & Radovich, M. (2017) · npj Breast Cancer · doi:10.1038/s41523-017-0028-4 · Cited by 120
High-Throughput Microfluidic Labyrinth for the Label-free Isolation of Circulating Tumor Cells
Lin, E., Rivera-Báez, L., Fouladdel, S., Yoon, H. J., Guthrie, S. M., Wieger, J., Deol, Y. S., Keller, E. T., Sahai, V., Simeone, D. M., et al. (2017) · Cell Systems · doi:10.1016/j.cels.2017.08.012 · Cited by 122
Risberg, B., Tsui, D. W. Y., Biggs, H., Ruiz-Valdepeñas, A., Dawson, S., Hodgkin, C., Jones, L. R., Parkinson, C., Piskorz, A., Marass, F., et al. (2018) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2018.07.005 · Cited by 121
Self-citationCirculating tumour cells—monitoring treatment response in prostate cancer
Miyamoto, D. T., Sequist, L. V. D., & Lee, R. J. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.82 · Cited by 122
Weiss, G. J., Ganeshan, B., Miles, K. A., Campbell, D. H., Cheung, P. Y.-C., Frank, S., & Korn, R. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100244 · Cited by 120
Metadata
- Authors
- Dawson, S.-J., Tsui, D. W. Y., Murtaza, M., Biggs, H., Rueda, O. M., Chin, S.-F., Dunning, M. J., Gale, D., Forshew, T., Mahler-Araujo, B., Rajan, S., Humphray, S., Becq, J., Halsall, D., Wallis, M., Bentley, D., Caldas, C., & Rosenfeld, N.
- Affiliations
- University of Cambridge (GB)
- National Health Service (GB)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2013-03-28
- Volume
- 368
- Issue
- 13
- Pages
- 1199-1209
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2140575188
- Cited by
- 2,207
- References
- 44
- Citations by year
- 2026: 86 · 2025: 96 · 2024: 106 · 2023: 109 · 2022: 169 · 2021: 180 · 2020: 197 · 2019: 220 · 2018: 197 · 2017: 224 · 2016: 204 · 2015: 195 · 2014: 135 · 2013: 82
- FWCI
- 72.15
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Cancer Research UK (11906, 16942, 22310)
- National Institute for Health and Care Research (NF-SI-0611-10154)
- NIHR Cambridge Biomedical Research Centre
- Cancer Research UK Cambridge Institute, University of Cambridge
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Keywords
- circulating tumor DNA, metastatic breast cancer, liquid biopsy, CA15-3, circulating tumor cells, treatment response monitoring, tumor burden, somatic alterations, circulating biomarkers, early detection of treatment response
- MeSH terms
- Breast Neoplasms, DNA, Neoplasm, Female, Humans, Mutation, Neoplasm Metastasis, Prognosis, Radiography, Sensitivity and Specificity, Biomarkers, Tumor, Sequence Analysis, DNA, Mucin-1, Tumor Burden, Genome-Wide Association Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
